Friday night Pandemic Watch - Swine Flu coming to you?

[Sweejak]

Even without this story there are plenty reasons not to take it.

You can't sue the vaccine makers or the ones who give it. They are immune to that.

The Baxter screw up in Eastern Europe and Baxter's previous screw up.

Gulf War syndrome... the list goes on.

[Fat Lady Singing]

So here are some sources for you. If I've left any out let me know!

Sadly, the links I clicked on in this post were almost all dead. Seems that online media is becoming more ephemeral than it used to be, even as it becomes a more popular source of information for audiences. Makes me glad that in the days I collected information of interest I clipped the entire article to an (offline) application called Notebook. Not that I'm saying you should have done so with these articles, chiggerbit, or that you should have posted them all here -- just that perhaps it's becoming more important to rescue info from the growing black hole gnawing away at history...

[chiggerbit]

Sadly, the links I clicked on in this post were almost all dead.

I saw that, and haven't had time to reconstruct them. (This is why I beileve in cutting and pasting most articles, myself.)

[chiggerbit]

http://slatest.slate.com/id/2227170/entry/4

Pigs To Be Vaccinated for Swine Flu


At least one pharmaceutical company, Pfizer, is preparing a vaccine that would protect pigs from the human strain of swine flu, according to the Washington Post. The U.S. Department of Agriculture gave several other manufacturers the "master seed virus" required to make the vaccines after becoming concerned that human swine flu could jump to pigs, as happened in a documented case earlier this year in Canada. In pigs, the virus could further mutate and jump back to humans as a more dangerous strain. Pfizer said that its vaccine could reach the market this fall, during peak flu season. Other manufacturers contacted by the Post either did not respond to inquiries about the pig vaccines or could not confirm whether they had any in development. The USDA said it will encourage but not require pig farmers to vaccinate their hogs.

[chiggerbit]

WHO says that more than 20% of known swine flu deaths have occurred in the last week. But apparently there is no indication that it has become more virulent. Of course, school has started in many areas of the US, so total numbers of people infected with the bug are up--a university in Washington state has 2000 cases there alone.

http://www.presstv.ir/detail.aspx?id=10 ... id=3510212

Record swine flu deaths is first week of September
Sat, 05 Sep 2009 17:15:08 GMT
Font size :

The new A/H1N1 virus has claimed the lives of more than 625 individuals in the past week, weeks before the start of the flu season.

Latest WHO figures revealed that some 254,206 individuals have tested positive for the new strain of H1N1, which was announced as a global pandemic in June.

More than 20 percent of the 2,837 known deaths from swine flu since its emergence in Mexico earlier this year have occurred in the past week.

The majority of these deaths have been reported in the Western Hemisphere.

Despite fears that the pandemic H1N1 influenza virus will recombine with seasonal flu to mutate into a more lethal form, WHO Spokesperson for Epidemic and Pandemic Diseases Gregory Hartl reported that "there is no sense that the virus has mutated or changed in any sense."

Hartl added that the United Nations agency is monitoring the strain to detect any mutation, which might signal that it has become more deadly.

[pepsified thinker]

How can they/anyone? account for the spike in deaths?

If this thing emerged in, say, April--I'm guessing there are earlier cases but not the 'WHAM' impact that put it in the news and showed widespread numbers of people infected--that's 5 months/20 weeks. To have 20% deaths in week 20 seems, um, odd.

[chiggerbit]

I'm not sure, but I think it's due to the increase in the number of people coming down with the bug. The problem is, at least here in the US, the CDC is doing very few tests now, so it's hard to tell just how fast it's spreading. I'd like to see a breakdown of deaths by country.

And remember, 20% worldwide amounting to 600+ still isn't that high a number.

[chiggerbit]

I really do trust that the CDC and WHO are worried about the infectiousness of this bug, not it's lethality at this point. Remember, this one is more deadly to the teens to younger adults than is usually the case. They're trying to get the healthcare people up to speed, but are worried that the sheer numbers could overwhelm hospitals and hospital equipment like ventilators, for instance. And that's assuming that the worst-case scenario doesn't happen. It could just as easily die out, but frankly, I'm stocking up on supplies, like toilet paper, food, pet food, Musinex, etc., because if the numbers are even half of what they're worried about when and if it hits here, grocery and drug store shelves could suddenly empty.

[chiggerbit]

One thing that's interesting to me--and I could be wrong about this--is that there doesn't seem to be any difference between the lethality in the Southern hemisphere's winter season than there's been here in the Northern hemisphere's summer season. Weird.

[seemslikeadream]

"Mock-up" pandemic vaccines bypass genuine safety testing, turning population into guinea pigs


(NaturalNews) Emails and information circulating on the 'net point to a rumor that the World Health Organization (WHO) has released a pandemic virus into the population via a "mock-up" vaccine. One story cites a WHO announcement (http://www.who.int/csr/disease/swin...) which explains:

Also in Europe, some manufacturers have conducted advance studies using a so-called "mock-up" vaccine. Mock-up vaccines contain an active ingredient for an influenza virus that has not circulated recently in human populations and thus mimics the novelty of a pandemic virus. Such advance studies can greatly expedite regulatory approval.

The point of these "mock-up" vaccines is to allow vaccine manufacturers to gain regulatory approvals for "placeholder" vaccines in advance of a pandemic. Once a pandemic appears, the vaccine manufacturer can then replace the "mock-up" viral strain in the vaccine with the newly emerging in-the-wild pandemic viral strain, thus speeding the time to market for the new pandemic vaccine.

This process is explained in more detail in this EMEA (European Medicines Agency) document:
http://www.emea.europa.eu/pdfs/gene...

It explains:

A mock-up pandemic influenza vaccine is a vaccine that mimics the future pandemic influenza vaccine in terms of its composition and manufacturing method. However, because the virus strain causing the pandemic is not known, the mock-up vaccine contains another flu strain instead. This is a strain that is not circulating in humans, and to which humans have not been exposed in the past. This enables the company to test its vaccine in preparation for any flu pandemic that may occur in the future, by carrying out studies with the mock-up vaccine that predict how people will react to the vaccine when the strain causing a pandemic is included.

There are two things I find quite concerning in this statement:

#1) The viral strain chosen for this mock-up is one that is not currently circulating in humans. Thus, they are choosing a viral strain to which humans have no acquired immune defense.

#2) These mock-up vaccines are tested on humans in order to "predict how people will react." Thus, the drug companies are engaged in injecting people with viral fragments that have never been previously encountered by humans.

Obviously, if mistakes are made in the processing of these vaccines, causing live viruses to be injected (instead of sufficiently weakened viruses), this could result in the spread of that new virus among the human population. Thus, there is the possibility that this process could be used as vector through which infectious disease is spread, but it all depends on which virus is chosen for the mock-up vaccines.

And that's never explained in any public documents that I could find. Where do the drug companies find these viruses to which humans have never been exposed? Are they getting them from military labs? Animal experiments? Are they specifically chosen to be similar to H1N1, or do they have a completely different protein configuration?

It is the selection of this viral strain that appears to be one of the most important factors in all this.



WHO isn't running these experiments
In any case, it's clear that this mock-up process is pursued by vaccine manufacturers, not the WHO itself, so I disagree with any report that states the WHO itself released a pandemic virus into the population. The WHO is merely explaining what a mock-up vaccine is. They aren't the ones manufacturing these mock-up vaccines or testing them on humans. That's being done by the drug companies.



US universities see early bouts of swine flu


Swine flu has begun to spread through American universities where more than 1,600 cases of A(H1N1) infections were recorded in the first week of classes, a health group said Thursday.
Some 1,640 new cases were reported at 165 universities across the country that participate in surveillance conducted by the American College Health Association.

There has been only one hospitalization and no fatalities attributed to the virus among the more than two million students who attend the schools, according to ACHA. There are more than 18 million college and university students nationwide.


But with more than 550 deaths attributed to swine flu across the United States since the virus emerged in April, and with 40 percent of global A(H1N1) fatalities being among young adults in good health, education authorities are trying to mitigate what ACHA has described as the "significant risk" of swine flu's spread in universities.

"It is a lot of cases and it's actually only one week," ACHA president James Turner said, referring to the 1,640 new infections.

"I wouldn't be surprised if we saw many more cases arrive on campuses and we see the outbreak accelerate," he told AFP.

Despite the concerns, Turner said he has spoken with several colleagues at universities across the country and that they report "a very mild disease that for the most part is not leaving students seriously ill.

"They feel miserable for three or four days but they don't seem to be getting complications, or pneumonia," he said.

Many universities are taking no chances, however, and there have been several reports of sick students confining themselves to their dorm rooms and student bodies being made aware of the dangers of swine flu.

"The concern from a public health standpoint is not so much the impact of the disease on otherwise healthy students, but the impact on those who are at risk of complication -- students with asthma, diabetes and heart disease."

ACHA says the state of Washington in the US northwest has the highest rate of infection at the reporting schools, with 124.3 cases per 10,000 students, followed by southern states Georgia (80.9) and Mississippi (43.2) and the central state of Kansas (31.3).






Safety of pandemic vaccines

6 AUGUST 2009 | GENEVA -- WHO is aware
of some media reports that have expressed concern about the safety of vaccines for pandemic influenza. The public needs to be reassured that regulatory procedures in place for the licensing of pandemic vaccines, including procedures for expediting regulatory approval, are rigorous and do not compromise safety or quality controls.

Vaccines are among the most important medical interventions for reducing illness and deaths during a pandemic. However, to have the greatest impact, pandemic vaccines need to be available quickly and in large quantities.


Pandemic influenza vaccine manufacturing process and timeline
6 August 2009


During the 1957 and 1968 pandemics, vaccines arrived too late to be used as an effective mitigation tool during the more severe phases of the pandemics. Influenza vaccines had not yet been developed when the 1918 pandemic swept around the world, eventually killing an estimated 50 million people.

In 2007, as part of preparedness for an influenza pandemic, WHO worked together with health officials, regulatory authorities, and vaccine manufacturers to explore a broad range of issues surrounding the regulatory approval of pandemic vaccines. [1]

Ways were sought to shorten the time between the emergence of a pandemic virus and the availability of safe and effective vaccines. Different regulatory pathways were assessed, and precautions needed to ensure quality, safety, and effectiveness were set out in detail.

Fast-track procedures for approval
Regulatory authorities have shown great flexibility in developing procedures for fast-tracking the approval and licensing of pandemic vaccines.

In some cases, pandemic vaccines are not regarded by regulatory authorities as entirely “new” vaccines, as they build on the technology used to produce vaccines for seasonal influenza, established procedures for testing and regulatory control, and an extensive body of safety data.

In such cases, approval procedures are similar to those applied to “strain changes” made each year when seasonal vaccines are modified to match circulating viruses in the Northern and Southern Hemispheres.

Specific regulatory procedures have been devised to expedite the approval of pandemic vaccines. In the USA, for example, fewer data are required when the manufacturer already has a licensed influenza vaccine and intends to use the same manufacturing process for its pandemic vaccine.

In the European Union, the European Medicines Agency uses a rolling review procedure whereby manufacturers can submit sets of data for regulatory review as they become available, without having to wait until all data can be submitted together in a single formal application.

Also in Europe, some manufacturers have conducted advance studies using a so-called “mock-up” vaccine. Mock-up vaccines contain an active ingredient for an influenza virus that has not circulated recently in human populations and thus mimics the novelty of a pandemic virus. Such advance studies can greatly expedite regulatory approval.

Special safety concerns
Influenza vaccines have been used for more than 60 years and have an established record of safety in all age groups. While some serious adverse events have been reported, these have been rare.

Nonetheless, special safety issues will inevitably arise during a pandemic when vaccine is administered on a massive scale. For example, adverse events too rare to show up even in a large clinical trial may become apparent when very large numbers of people receive a pandemic vaccine.

Some adverse events will be coincidental – that is, associated in time with vaccine administration, yet not directly caused by the vaccine. Genuine adverse events directly caused by the vaccine may also occur, but cannot be predicted in advance. Given the safety record of seasonal vaccines, such events are expected to be rare.

Time constraints mean that clinical data at the time when pandemic vaccines are first administered will inevitably be limited. Further testing of safety and effectiveness will need to take place after administration of the vaccine has begun.

For these reasons, WHO advises all countries administering pandemic vaccines to conduct intensive monitoring for safety and efficacy, and many countries have plans in place for doing so. On the positive side, mass vaccination campaigns can generate significant safety data within a few weeks.

International sharing of data from such post-marketing surveillance will be vital in guiding risk-benefit assessments and determining whether changes in vaccination policies are needed. WHO has developed standardized protocols for data collection and reporting in real-time, and will communicate findings to the international community via its web site.

As the WHO document itself says here:

"Specific regulatory procedures have been devised to expedite the approval of pandemic vaccines. In the USA, for example, fewer data are required when the manufacturer already has a licensed influenza vaccine and intends to use the same manufacturing process for its pandemic vaccine.

In the European Union, the European Medicines Agency uses a rolling review procedure whereby manufacturers can submit sets of data for regulatory review as they become available, without having to wait until all data can be submitted together in a single formal application.

Also in Europe, some manufacturers have conducted advance studies using a so-called “mock-up” vaccine. Mock-up vaccines contain an active ingredient for an influenza virus that has not circulated recently in human populations and thus mimics the novelty of a pandemic virus. Such advance studies can greatly expedite regulatory approval."

[Skunkboy]

I don't know if this has been posted before, but the info contained is very valuble.

http://www.knowthecause.com/Newsletter/ ... e-Flu.aspx

Current Articles | Archives | Search
31Swine Flu
Lynn Jennings MD posted on August 31, 2009 12:10
Dear Readers,

September has always signaled the end of summer vacation and the beginning of a new school year. In Michigan, where I grew up, the school year always began the week after Labor Day. (It also corresponded with the new fall lineup of shows on TV, three channels, no such thing as cable). As a physician, I am aware of the seasonal trends of illness. Within a few weeks of the start of the new school year, I could always count on the increase in sore throats, coughs and colds. When you put a large group of people (children) in close contact with one another, a lot of germs get spread around. And that brings me to the topic I would like to discuss, the H1N1 virus more commonly known as the “swine flu virus.” This article was prompted by an evening web seminar that was presented by Dr. Sherri Tenpenny a few weeks ago. The information was startling. I decided that this information needed to be passed on.

H1N1 flu virus (swine flu) is a new influenza virus causing illness in people. The virus was first detected in people in the United States in April 2009. The World Health Organization has declared the H1N1 flu to be a pandemic. When you start tossing the word pandemic around, people get frightened. What does pandemic mean? The definition of pandemic is an outbreak of infectious disease that effects people over a widespread area in multiple countries or even worldwide. According to the World Health Organization (WHO), a pandemic can start when three conditions have been met:

• Emergence of a disease new to a population;
• Agents infect humans, causing serious illness; and
• Agents spread easily and sustainably among humans. 1

The H1N1 virus is spreading from person-to-person, probably in much the same way that regular seasonal influenza viruses spread. In fact, the CDC estimates that 100 million people will have been mildly infected with the H1N1 virus by the end of the summer.1 Based on the idea that exposure to a virus will cause the development of immunity to the virus, doesn’t it seem as though these same people would have developed a natural immunity to the virus? That is the basic theory behind vaccinations. So why is there a rush to implement a massive vaccination program?

Follow the money. The U.S. government has already spent over $1.8 billion dollars (our tax dollars) in purchasing vaccine antigen, virus and adjuvant from five pharmaceutical companies. So what did the government buy with our money, who got it and how much did they receive?

Bulk vaccine Bulk virus Bulk oil and water antigen concentrate adjuvant
Sanofi-Pasteur 252,425,000
GSK 38,000,000 215,400,000 (AS03/AS04)
Novartis 496,334,450 482,810,470 (MF-59)
CSL Biotherapies 180,000,000
Medimmune 90,000,000 61,020,000
1,056,759,450 61,020,000 698,210,470

Grand total: $1,815,989,920 (2)

That’s an incredible amount of money to spend. What is an adjuvant? An adjuvant is a substance that is added to the vaccine to improve the immune response. The adjuvants our government has purchased are: AS03, AS04 and MF-59.

MF-59 is an oil based adjuvant that contains squalene. Squalene is a highly inflammatory substance that been shown to induce hyperimmune responses. It is this hyperimmune response that causes problems. Studies in humans given from 10 to 20 ppb (parts per billion) of squalene showed severe immune system impact and development of autoimmune disorders.3

Squalene in vaccines has been strongly linked to the Gulf War Syndrome. This remains a controversial subject and is related to the anthrax vaccine given to the military. One study found that deployed Persian Gulf War Syndrome patients were significantly more likely to have squalene antibodies (95 percent) than asymptomatic Gulf War veterans.4,5 This raises the possibility that squalene was used in the anthrax vaccine given to soldiers prior to deployment in the Persian Gulf War to better induce immunity. In August 1991, the Secretary of Veterans Affairs admitted that soldiers vaccinated with the anthrax vaccine from 1990 to 1991 had an increased risk of 200 percent in developing the deadly disease amyotrophic lateral sclerosis (ALS), also called Lou Gehrig’s disease. The soldiers also suffered from a number of debilitating and life-shortening diseases, such as polyarteritis nodosa, multiple sclerosis (MS), lupus, transverse myelitis (a neurological disorder caused by inflammation of the spinal cord), endocarditis (inflammation of the heart’s inner lining), optic neuritis with blindness and glomerulonephritis (a type of kidney disease).6 These can all be considered autoimmune diseases.

AS03 and AS04 are proprietary adjuvants of GlaxoSmithKline. It is very difficult to find any useful information about them. What I can tell you is that these adjuvants both contain aluminum.

Aluminum is neurotoxic even in minute amounts. The Academy of Pediatrics implicates aluminum in autoimmune conditions. These conditions include chronic fatigue syndrome and macrophagic myofasciitis. Macrophagic myofasciitis is a condition that causes profound weakness and multiple neurologic symptoms. Aluminum hydroxide is known to potently stimulate the immune system and to shift immune responses towards an inflammatory profile.7 Both the CDC and WHO are aware that aluminum is dangerous. It has also been suggested that aluminum toxicity is the real problem behind autism, SIDS and the side effects associated with the HPV vacccine.8

At present AS04, AS03 and MF-59 have not been approved by the FDA for use in the United States. However, on July 30, 2009, US Health and Human Services Secretary Kathleen Sebelius confirms that the Swine Flu (H1N1) vaccine will be laced with the mercury based preservative thimerosal.9

Let’s address the current clinical trials that are going on. There has been a lot of news about the rush of people volunteering for the vaccine. Did you know that the volunteers will be paid for their participation.10 Initial studies will look at whether one or two 15 microgram doses of H1N1 vaccine are needed to induce a potentially protective immune response in healthy adult volunteers (aged 18 to 64 years old) and elderly people (aged 65 and older). Researchers also will assess whether one or two 30 microgram doses are needed. The doses will be given 21 days apart, testing two manufacturers’ vaccines (Sanofi Pasteur and CSL Biotherapies). If early information from those trials indicates that these vaccines are safe, similar trials in healthy children (aged 6 months to 17 years old) will begin.11

A concurrent set of trials will look at the safety and immune response in healthy adult and elderly volunteers who are given the seasonal flu vaccine along with a 15 microgram dose of 2009 H1N1 vaccine. The H1N1 vaccine will be given to different sets of volunteers before, after, or at the same time as the seasonal flu vaccine. If early information from those studies indicates that these vaccines are safe, similar trials in healthy children (aged 6 months to 17 years old) will start.11 The vaccine used in all of the above clinical trials will not contain adjuvant. That’s right, no adjuvant. The expected study completion date is April 2010. This begs the question, how can they make a determination of the safety of the vaccine before the anticipated “swine flu season” this fall and winter?

Now here is the information that unnerves me. On April 26, 2009, it was officially determined that a public health emergency exists nationwide involving the H1N1 virus and that it has significant potential to affect the national security. As a result of this in June 2009, DHHS Secretary Kathleen Sebelius (via an amendment to PREPA) gave immunity to the pharmaceutical companies involved in supplying the H1N1 vaccine and adjuvants. PREPA stands for Public Readiness and Emergency Preparedness Act.12 This act allows the Secretary of the Department of Health and Human Services to invoke almost complete immunity from liability for vaccine and drug manufacturers. If the vaccines are used during a declared public health emergency it also shields government program planners and health officials who administer the vaccine. No one can sue for compensation unless: a) they can prove willful misconduct that resulted in death or serious injury and b) they get permission to sue from the Secretary of the Department of Health and Human Services. (That is where the phrase “almost complete immunity” comes in.) The government believes that it is encouraging the design, development, clinical testing, investigation and manufacture of a “medical countermeasure” (vaccine).12 It seems obvious to me that the granting of immunity is actually a disincentive to further research on the safety of the vaccine and adjuvants.

CDC’s Advisory Committee on Immunization Practices (ACIP), a panel made up of medical and public health experts, met July 29, 2009, to make recommendations on who should receive the new H1N1 vaccine when it becomes available. When vaccine is first available, the committee recommended that programs and providers try to vaccinate:

• pregnant women
• people who live with or care for children younger than 6 months of age
• health care and emergency services personnel
• persons between the ages of 6 months through 24 years of age
• people from ages 25 through 64 years who are at higher risk for novel H1N1 because of chronic health disorders or compromised immune systems.

The groups listed above total approximately 159 million people in the United States.13

Is the flu vaccine likely to be effective? Numerous studies have documented that flu shots give little or no protection against infection and illness and there is no reason to believe that swine flu vaccines will be different. The flu virus changes quickly. Furthermore, flu vaccination does not give permanent protection, and must be repeated annually.

A review of 51 separate studies in 2006 concluded that flu vaccines worked no better than a placebo in 260,000 children ranging in age from six months to 23 months. A report published in 2008 found flu vaccines in young children made no difference in the number of flu-related doctor and hospital visits. However, a study of 800 children with asthma found that those receiving a flu vaccine had a significantly increased risk of asthma-related doctor and emergency room visits.3

Is it likely that the government will make vaccination mandatory? The law is very vague with regards to this. However, since 9/11 the U.S. government has made even more moves to clear the way for agencies like the Depts. of Homeland Security and Health and Human Services to interfere in your freedom to choose.

• The Project Bioshield Act of 2004 gives NIH the authority to fast track drugs and vaccines deemed “qualified medical countermeasures” against threats to public health.
• Executive Order 13375, effective in 2005, amends Executive Order 13295, which gives the Secretary of HHS the power to detain, examine and quarantine indefinitely any individual thought to be infected with a communicable disease.
• The 2006 Division E -- Public Readiness and Emergency Preparedness Act gives the Secretary of HHS the power to recommend the development and administration of covered countermeasures, defined as a “pandemic product, vaccine or drug.” 14

Historically, the preservation of the public health has been the responsibility of state and local governments. With respect to the preservation of the public health in cases of communicable disease outbreaks, these powers may include the institution of quarantine or the enactment of mandatory vaccination laws. Many states have laws providing for mandatory vaccinations during a public health emergency or outbreak of a communicable disease. Generally, the power to order such actions rests with the governor of the state, the state board of health, or the state health officer.15

How can you survive the “swine flu” without getting a flu shot? Keeping your immune system healthy is the best and most effective defense. How do you do that? Many of these things you probably already know but may not have put them into place.

• Get adequate amounts of rest. Irregular sleeping patterns, inadequate sleep all cause stress on your body and can adversely affect your immune system.
• Wash your hands.
• Maintain a healthy diet. You need to limit your intake of refined sugar and grains. You should also stay away from artificial sweeteners such as saccharin, aspartame and splenda.
Eat plenty of green and purple vegetables. The majority of your diet should be vegetables and fruits. The initial phase diet is an excellent start.
• Regular exercise. You don’t have to be a marathon runner. Walking is good. Do what you can. If you cannot walk, arm exercises are good.
• Make sure you are getting adequate amounts of Vitamin D3. A good starting dose would be 5000 units per day until you can have your doctor or health care provider check your 25 hydroxy vitamin D3 level. Recommended levels are 50-70.
• Vitamin C 4000-6000mg daily.
• Zinc citrate 25mg daily
• Selenium 50ug daily
• I would also recommend an iodine supplement (if you are not allergic)
• such as Iodoral 12.5-25mg daily
• Take daily probiotics.

There is much more information out there. I have to admit that I was so unnerved after the seminar that I had to verify the information presented by Dr. Tenpenny. I had to do my homework. The references are listed at the end of this article so that you can expand on what is presented here. What happens if I don't want to take the flu vaccine? Next month, we will discuss your options and what you can do. Knowledge is power.

Blessings,

Lynn Jennings, M.D.

1. www.pandemicflu.gov (U.S. Department of Health and Human
Services official website)
2. www.medicalcountermeasures.gov (U.S. Department of Health andHuman Services official website)
3. www.i-sis.org.uk Fast-tracked Swine Flu Vaccine under Fire,
Dr. Mae-Won Ho and Prof. Joe Cummins (Institute of Science in Society) July 27, 2009
4. Asa, PB et al., Antibodies to Squalene in Gulf War Syndrome.
Experimental and Molecular Pathology 68, 55–64 (2000).
5. www.autoimmune.com, Antibodies Link Gulf War Syndrome to
Anthrax Vaccine. Autoimmune Technologies. July 15, 2002.
6. www.newsmax.com. Vaccine May Be More Dangerous Than Swine Flu.
Blaylock, R, July 24, 2009
7. Gherardi, RK, Lesson from macrophagic myofasciitis: towards a
definition of a vaccine adjuvant-related syndrome.
Rev Neurol (Paris)2003 Feb;159(2):162-4.
8. www.thinktwice.com Aluminum in Vaccines: A Neurologic Gamble
Neil Z Miller
9. www.homefirst.com Swine Flu Vaccine Will Contain Mercury.
Washington Post, July 30, 2009.
10.www.paidclinicaltrials.org
11.www.nih.gov NIAID Set to Launch Clinical Trials to Test 2009
H1N1 Influenza Vaccine Candidates, July 22, 2009.
12. Federal Register: June 25, 2009 (Volume 74, Number 121)
Page 30294-30297.

13. www.cdc.gov CDC Advisors Make Recommendations for Use of
Vaccine Against Novel H1N1. July 29, 2009.
14. What are the dangers of mandatory swine flu vaccination? Dr.
Mercola, June 2009.
15. www.fas.org Welborn, AA, Mandatory Vaccinations: Precedent and
Current Laws. CRS Report for Congress January 18, 2005


Posted in: Lynn Jennings, M.D., September 2009
Actions: E-mail | Permalink | Kick it! | DZone it! | del.icio.us

[StarmanSkye]

Steve Lendman's latest article detailing how and why the H1N1 'pandemic' is being hyped as a massive psyop boondoggle. Recent mass media reports about increased Swine Flu cases are very suspect because WHO had earlier this summer said it was going to stop testing, confirming and detailed recording of Swine Flu rates.

Also, given that ordinary influenza routinely has far, far more fatalities than yet seen with Swine Flu, its very hard to understand the WHO's focus and the US government's administrative and legislative urgency in promoting and expediting a massive, widespread vaccination program with unprecedented legal authorization. I think there is great cause to be skeptical about the real agenda here. From what I've read so far, I don't expect to ever consent to taking this viral stew of actual and potential poisons.

*******
http://www.opednews.com/articles/Martia ... 7-922.html
Martial Law Alert Over Swine Flu
By Stephen Lendman

Fact check:
-- no Swine Flu threat exists;
-- reported H1N1 infections and deaths are uncorroborated;
-- WHO predicting a global pandemic affecting "as many as two billion people....over the next two years" is falsified hype unless a diabolical depopulation scheme (by vaccines or other means) plans to create one;
-- vaccines don't protect against diseases they're designed to prevent and often cause them;
-- all vaccines contain harmful toxins, including mercury, aluminum, formaldehyde, phenoxyethanol (antifreeze), and squalene adjuvants that weaken and can destroy the human immune system, making it vulnerable to many annoying to life-threatening illnesses; and
-- evidence suggests that the H1N1 strain was bioengineered in a US laboratory, and the vaccines being produced for it are extremely hazardous and potentially lethal.

Under no circumstances should anyone submit to them even if threatened with fines, quarantine, or incarceration.

Government and PhRMA Are Enemies, Not Protectors
On April 26, the US Department of Health and Human Services (HHS) issued a "Determination that a Public Health Emergency Exists....as a consequence of confirmed cases of H1N1 Influenza in four US states." At an April 27 press briefing, Homeland Security (DHS) Secretary Janet Napolitano said:
Yesterday "I issued a public health emergency declaration" as part of "standard operating procedure" to make more government resources available to combat the spread of Swine Flu. She then ordered the FDA "to proceed to permit things like Tamiflu to be used for populations that they otherwise wouldn't be used for - in this case, for example, very, very young children."

On November 13, 2005, Japan's Health Ministry said it was "looking into reports of a number of sudden deaths of young people who had taken prescribed dosages of Tamiflu." The Ministry also "found 64 cases of psychological disorders linked to the drug in the past four years."

The Japan Institute of Pharmaco-Vigilance head, Dr. Rokura Hama, said "Tamiflu appears to be similar to other powerful drugs that can cause behavioral changes" by affecting the central nervous system. It's the leading medication prescribed for the treatment and prevention of flu. In April, DHS ordered 12 million doses made available in locations around the country for quick access if needed.

Then on June 11, the World Health Organization (WHO) "raise(d) the level of (Swine Flu) influenza pandemic alert from phase 5 to phase 6," its highest level in declaring "The world is now at the start of the 2009 influenza pandemic," while admitting its severity would likely be "moderate (and) most people will recover from swine flu within a week, just as they would from seasonal forms of influenza." The WHO no longer reports "confirmed" Swine Flu cases globally, yet continues to hype the scare without corroborating proof.

There was no emergency earlier or now, but you'd never know it from hyped media reports to convince people voluntarily to submit to experimental, untested, toxic and extremely dangerous vaccines that damage the human immune system and cause health problems ranging from annoying to life-threatening.

George Bush's Executive Orders (EOs) 13295 and 13375, Homeland Security Presidential Directive-21, and Military Pandemic Planning
In addition to the federal laws below, the Bush EOs, HSPD-21, and Pentagon plan suggest a hidden agenda behind today's Swine Flu crisis as a way to institute martial law on the pretext of a public health emergency, using hyped fear to win popular acquiescence.

On April 4, 2003, EO 13295 issued a "Revised List of Quarantinable Communicable Diseases" that included cholera, diphtheria, infectious TB, plague, smallpox, yellow fever, severe acute respiratory syndrome (SARS), and viral hemorrhagic fevers like ebola and lassa.
On April 1, 2005, EO 13375 amended EO 13295 by adding "the following new subsection:"

"(c) Influenza caused by novel or reemergent influenza viruses that are causing, or have the potential to cause, a pandemic."
The October 2007 HSPD-21 "establishe(d) a National Strategy for Public Health and Medical Preparedness which builds upon principles set forth in (the 2004) Biodefense for the 21st Century and will transform our national approach to protecting the health of the American people against all disasters."

It called for:
-- "nationwide, robust, and integrated biosurveillance...to provide early warning and ongoing characterization of disease outbreaks in near real-time;
-- countermeasure stockpiling and distribution....of medical countermeasures (vaccines, drugs, and therapeutics) to a large population....;
-- mass casualty care....created by a catastrophic health event;" and
-- "community resilience" whereby "civic leaders, citizens, and families are educated regarding threats and are empowered to mitigate their own risk;" in addition, the federal government must be involved in "medical preparedness to assist (nationwide) in the face of potential catastrophic health events."

In May 2007, the Department of Defense's (DOD) "Implementation Plan for Pandemic Influenza" prepared for a possible H5N1 (Avian Flu) pandemic that could affect up to one-third of the population and kill as many as three million in just weeks, it was claimed. It involved using US troops to put down riots, guard pharmaceutical plants and shipments, and restrict the movement of people inside the country and across borders.

This plan remains active and US laws authorize it, including Sections 1076 and 333 of the John Warner National Defense Authorization Act for Fiscal Year 2007 that amended the 1807 Insurrection Act and 1878 Posse Comitatus Act. They prohibit using federal and National Guard troops for law enforcement except as constitutionally allowed or expressly authorized by Congress in times of a national emergency like an insurrection.

The president may now announce a public emergency, declare martial law, suspend the Constitution, and deploy US troops on city streets to suppress what he calls disorder.

The Legal Basis for Quarantines
(snip; see link for rest of article)

[chiggerbit]

Hah, I thought this might trip some conspiracy triggers:

http://www.news-releases.uiowa.edu/2009 ... arket.html

May 4, 2009

Iowa Electronic health Market opens H1N1 swine flu prediction markets

The Iowa Electronic health Market has opened several new markets to track and forecast trends in the current H1N1 swine flu outbreak.

"Information generated by this research project will not replace existing surveillance systems, but we think our prediction markets may provide a useful supplement," said Philip Polgreen, M.D., assistant professor of internal medicine at the University of Iowa's Carver College of Medicine and co-director of the IEhM.

The IEhM is a spin-off from the Iowa Electronic Market (IEM), which pioneered the first prediction markets in 1988. Since that time, prediction markets have proven to be more accurate than traditional tools in predicting future events ranging from political election results to movie box office receipts; they are also used by the private sector to forecast outcomes such as which drugs have the best chance of advancing through clinical trials or which printers will sell. The IEhM is the first research group to use prediction markets for public health issues.

"To date, the IEhM has run markets to predict seasonal influenza activity at a state level and also the number of avian influenza cases. Both of these markets have provided accurate and timely infectious disease forecasts," said Forrest Nelson, professor of economics at the University of Iowa's Tippie College of Business and the IEhM's director.

The H1N1 influenza (swine flu) market can be found online with the IEhM's other health markets at http://iehm.uiowa.edu. Initial offerings in the market serve to aggregate information on five separate questions:

--How long will the current outbreak last in the United States?
--How many U.S. states will be affected?
--How many cases will be confirmed in the U.S.?
--What will the mortality rate be among confirmed cases?
--How many other countries will be affected?

The IEhM is currently recruiting members of the clinical, public health and animal health communities to participate. Applications from people in other fields will also be considered.

The H1N1 market does not use real money. Traders receive 100 "H1N1 dollars" when they sign up for their account, and this token currency is used for buying and selling contracts.

The market works as a prediction market by determining the probability of event outcomes. One contract is associated with each possible outcome of an event. After the actual outcome is observed, the associated contract will be worth H1N1$1, while the others will be worth H1N1$0. Prior to the event, traders who think a particular outcome will occur bid up the price of the associated contract; those who think it unlikely to occur bid it down. The price that emerges can be interpreted as the consensus view of the probability that the outcome will occur.

STORY SOURCE: University of Iowa News Service, 300 Plaza Centre One, Iowa City, Iowa 52242-2500

[tazmic]

'Alternate Futures for 2025: Security Planning to Avoid Surprise' (1996)

Digital Cacophony:
page 55, graphic - 2009 'Influenza kills 30 million'

[chiggerbit]

Arkansas has announced four additional deaths due to swine flu, bringing that state's total to five. The first was August 10, so all five in about the last month. The announcement lacks specifics:

http://www.todaysthv.com/news/local/sto ... 18&catid=2

The Arkansas Department of Health reported four additional deaths among Arkansans from complications related to 2009 influenza A (H1N1) virus.


These additional deaths bring the total to five Arkansans who have died this year from the 2009 H1N1 flu. The first death in the state from the H1N1 flu was reported on August 10....